These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Higher Estradiol and Lower Dehydroepiandrosterone-Sulfate Levels Are Associated with Pulmonary Arterial Hypertension in Men. Ventetuolo CE; Baird GL; Barr RG; Bluemke DA; Fritz JS; Hill NS; Klinger JR; Lima JA; Ouyang P; Palevsky HI; Palmisciano AJ; Krishnan I; Pinder D; Preston IR; Roberts KE; Kawut SM Am J Respir Crit Care Med; 2016 May; 193(10):1168-75. PubMed ID: 26651504 [TBL] [Abstract][Full Text] [Related]
30. Primary pulmonary hypertension: an overview of epidemiology and pathogenesis. Ghamra ZW; Dweik RA Cleve Clin J Med; 2003 Apr; 70 Suppl 1():S2-8. PubMed ID: 12716137 [TBL] [Abstract][Full Text] [Related]
31. The serotonin transporter, gender, and 17β oestradiol in the development of pulmonary arterial hypertension. White K; Dempsie Y; Nilsen M; Wright AF; Loughlin L; MacLean MR Cardiovasc Res; 2011 May; 90(2):373-82. PubMed ID: 21177701 [TBL] [Abstract][Full Text] [Related]
32. Dehydroepiandrosterone: A new treatment for vascular remodeling diseases including pulmonary arterial hypertension. Dumas de la Roque E; Savineau JP; Bonnet S Pharmacol Ther; 2010 May; 126(2):186-99. PubMed ID: 20206649 [TBL] [Abstract][Full Text] [Related]
33. Update on pediatric pulmonary arterial hypertension. Differences and similarities to adult disease. Saji T Circ J; 2013; 77(11):2639-50. PubMed ID: 24152725 [TBL] [Abstract][Full Text] [Related]
34. Sex differences and sex steroids in lung health and disease. Townsend EA; Miller VM; Prakash YS Endocr Rev; 2012 Feb; 33(1):1-47. PubMed ID: 22240244 [TBL] [Abstract][Full Text] [Related]
35. 4,4'-Methylenedianiline Alters Serotonergic Transport in a Novel, Sex-Specific Model of Pulmonary Arterial Hypertension in Rats. Carroll-Turpin M; Hebert V; Chotibut T; Wensler H; Krentzel D; Varner KJ; Burn BR; Chen YF; Abreo F; Dugas TR Toxicol Sci; 2015 Sep; 147(1):235-45. PubMed ID: 26116029 [TBL] [Abstract][Full Text] [Related]
36. Pulmonary arterial hypertension in congenital heart disease: translational opportunities to study the reversibility of pulmonary vascular disease. van der Feen DE; Bartelds B; de Boer RA; Berger RMF Eur Heart J; 2017 Jul; 38(26):2034-2041. PubMed ID: 28369399 [TBL] [Abstract][Full Text] [Related]
38. Pulmonary arterial hypertension and the potential roles of metallothioneins: A focused review. Maarman GJ Life Sci; 2018 Dec; 214():77-83. PubMed ID: 30355531 [TBL] [Abstract][Full Text] [Related]
39. The influence of sex hormones on pulmonary vascular reactivity: possible vasodilator therapies for the treatment of pulmonary hypertension. Smith AM; Jones RD; Channer KS Curr Vasc Pharmacol; 2006 Jan; 4(1):9-15. PubMed ID: 16472172 [TBL] [Abstract][Full Text] [Related]